June 14, 2019

New Data Released by Theratechnologies Demonstrate Positive Impact of Tesamorelin in Patients with Liver Fibrosis

Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce additional data from the recently completed study funded by the National Institutes of Health, led by Dr. Steve Grinspoon, and conducted at the Massachusetts General Hospital and Harvard Medical School and the National Institutes of Health.